ArticleBlood advances2021

Long-term outcomes of R-CEOP show curative potential in patients with DLBCL and a contraindication to anthracyclines.

Alden A Moccia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.